News & stories
Free access to the SPIRIT Electronic Protocol Tool and Resource (SEPTRE) platform
The Global Health Network, EDCTP, and Women’s College Hospital at the University of Toronto have extended their partnership to provide continued access to the SPIRIT…
CAP012 SAMBA project: African innovation driving the future of HIV prevention
The CAP012 SAMBA project, led by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and supported by the EDCTP2 programme, represents…
Portable molecular testing brings life-saving TB diagnosis closer to communities in sub-Saharan Africa
The TB-CAPT CORE study has found that implementing rapid molecular tuberculosis (TB) testing at primary health care clinics in sub-Saharan Africa is feasible and…
REVIVE-IPTp: Strengthening communities to prevent malaria in pregnancy in western Kenya
Malaria remains a critical threat to maternal and infant health in sub-Saharan Africa, with devastating consequences that include severe anaemia and postpartum haemorrhage in mothers,…
Burundi joins the EDCTP Association
The EDCTP Association is pleased to announce that Burundi has become its newest member country, bringing the total number of participating African countries to 31.…
bEto-TB achieves key milestones in advancing drug-resistant tuberculosis treatment
At the end of August 2025, BioVersys AG announced that the European Medicines Agency’s Committee for Orphan Medicinal Products (EMA COMP) had granted orphan designation…
Professor Marcel Tanner steps down as High Representative of the EDCTP Association
Professor Marcel Tanner has concluded his nearly decade-long tenure as the High Representative of the EDCTP Association, marking the end of an extraordinary chapter in…
EDCTP Annual Report 2024: Achieving real impact
As more EDCTP2-funded projects finish and share their findings, it’s clear that the programme is making a significant impact on health in sub-Saharan Africa. The…
Promising alternative drugs for TB treatment identified in clinical studies
Clinical studies have revealed two promising antibiotics, sutezolid and delpazolid, as potential safer alternatives to the drug linezolid for treating tuberculosis (TB). These findings, part…
First malaria treatment for babies and young infants receives approval
Swissmedic has granted authorisation of Coartem® (artemether-lumefantrine) Baby as the first malaria treatment specifically for young infants weighing less than 5 kg. This milestone follows…
Prof. George Boateng Kyei: advancing HIV research in Africa
In his EDCTP-GSK Senior Fellowship, Professor George Boateng Kyei of the Noguchi Memorial Institute for Medical Research, University of Ghana, has not only advanced the…
New antiretroviral combinations show promise for children living with HIV
The CHAPAS-4 trial has presented important advancements in second-line antiretroviral therapy for children living with HIV. Published in the New England Journal of Medicine, the…
World Malaria Day 2025: reinvest, reimagine and reignite our commitment to end malaria
On this World Malaria Day, we reflect on the theme ‘Malaria Ends with Us: Reinvest, Reimagine, Reignite.’ This theme serves as a reminder that over…
World TB Day 2025: Our commitment to combatting tuberculosis
On this year’s World TB Day, EDCTP unites with global partners in the belief that the tuberculosis epidemic can be ended. The theme, “Yes! We…
First preschool-aged child receives arpraziquantel for schistosomiasis treatment
The Pediatric Praziquantel Consortium has announced that the first preschool-aged child has been treated with arpraziquantel, a new pediatric treatment for schistosomiasis, in Uganda. This…